Related Experiment Videos
Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis
1Department of Rheumatology, Umed University Hospital, Sweden. Agneta.Uddhammar.us@vll.se
Clinical and Experimental Rheumatology
|August 19, 2000
Abstract:
Patients with giant cell arteritis (GCA) and with polymyalgia rheumatica (PMR) have increased plasma levels of von Willebrand factor (vWF) even during corticosteroid therapy. The association between vWF, subclinical inflammation and cardiovascular complications in GCA/PMR remains to be investigated.